Table 2.
No. | Clinical manifestation | COVID-19 | Dengue infection |
---|---|---|---|
1. | Fever |
No specific fever patterns. Defervescence after 6 days of illness [33] |
Saddleback fever (fever with two peaks) [8] |
2 | Headache | 6.5–13.6% [30, 32, 35] | 45–95% [8, 28] |
3 | Myalgia | 15–44% [27, 30–32] | 12% [8] |
4 | Cough | 76% [30] | 21.5% [37] |
5 | Dyspnea | 55% [30] | 9.5–95.2% [38] |
6 | Diarrhea | 2–34% [27, 30–32] | 6% [8] |
7 | Abdominal pain | 2% [31, 32] | 17–25% [28, 41] |
8. | Vomiting | 4–5% [31, 32, 35] | 30–58% [8, 41] |
9 | Cutaneous manifestation | Erythematous rash, urticaria, chickenpox-like vesicles [66] | Skin flushing that blanches on pressure, petechiae, and convalescent rash [8, 64] |